ConvaTec's owners have appointed Morgan Stanley (MS.N) and Goldman Sachs (GS.N) to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.
Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages.
Bristol-Myers Squibb is reportedly exiting its stake in a diabetes joint venture with AstraZeneca for $3 billion. Bristol-Myers shifted its focus from producing diabetes and hepatitis C treatment drugs to medicines harnessing the immune system to fight cancer.